Supreme Court Keeps Telehealth Abortion Access Intact for Now
Cover image from slate.com, which was analyzed for this article
A Supreme Court dissent signals potential future challenges to state abortion restrictions. Advocates on both sides prepare for ongoing legal battles.
PoliticalOS
Saturday, May 16, 2026 — Politics
The Court has kept telehealth mifepristone access available during ongoing litigation, but the dissents and pending FDA review indicate that statutory and regulatory disputes will continue. Readers should track both the lower-court proceedings and any changes in agency enforcement policy rather than treating the current stay as a final resolution.
What outlets missed
Neither outlet quoted the precise language of the 1873 Comstock Act or the 2022 DOJ memo interpreting its scope. Coverage also omitted the specific timeline of the FDA safety review initiated in late 2025 and the replacement of Commissioner Marty Makary by Kyle Diamantas. The 7-2 vote tally and the fact that the stay preserves rather than expands access received only passing mention in one account. Data on state-level enforcement patterns after Dobbs and the comparative safety statistics versus childbirth were presented without parallel figures from government health agencies.
You've seen the spin. Now read what happened.
The unbiased version strips away everything the other four added: the framing, the omissions, the selective emphasis. Just what happened.
Read all five, free for 7 days$4.99/mo after trial. Cancel anytime.